Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
The researchers evaluated the impact of antirheumatic treatment in women who are pregnant with psoriatic arthritis and how such treatment affects pregnancy outcomes.
This COVID-19 roundup includes research on an alternative therapy to nirmatrelvir-ritonavir, a vaccine regimen that protects pregnant women and infants against certain variants, pegylated interferon lambda...
Researchers compared pre-exposure prophylaxis (PrEP) use with birth outcomes using objective levels of tenofovir-diphosphate (TFV-DP) in dried blood spots (DBS) of women during the second or third trimester...
In a recent clinical trial, researchers determined that mothers who took vitamin D supplements during pregnancy reduced the risk of atopic eczema in the baby’s first year.
Researchers conducted an observational study that examined the likelihood of newborns and infants having measles antibodies passed down from their mothers.
This COVID-19 roundup includes coverage on a revised version of the FDA’s emergency use authorization of tixagevimab/cilgavimab, a new study that compared the efficacy of vaccines and boosters in mortality...
According to a study, pregnant women without a previous diagnosis of hypertension developed postpartum hypertension—some more than 6 weeks after delivery.
